Basilea initiiert zielgerichtete, Biomarker-basierte Phase-2-Studie mit Lisavanbulin bei Patienten mit Hirntumoren

NEXT STORY
Global Licorice Root Market Report 2020-2026 Featuring Profiles of Producers – NOREVO GmbH, Herbs Iran, Naturex SA
PREV STORY
Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receipt of $15 Million Upfront Payment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CareDx Drives Personalized Medicine in Transplantation at CEOT

author_avatar
NASDAQ Market News

Global Direct-to-Consumer Genetic Testing Market Research Report 2021: Capitalizing on the High Prevalence of Genetic Disorders & Mushrooming DTC Genetic Testing Services Market

author_avatar
NASDAQ Market News

CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors

CAMBRIDGE, Mass., March 15, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a Phase ...

author_avatar
NASDAQ Market News